{"id":128,"date":"2023-12-13T09:45:33","date_gmt":"2023-12-13T09:45:33","guid":{"rendered":"http:\/\/gebro.es\/?page_id=128"},"modified":"2026-02-25T13:42:57","modified_gmt":"2026-02-25T13:42:57","slug":"business-development-and-innovation","status":"publish","type":"page","link":"https:\/\/gebro.es\/en\/business-development-and-innovation\/","title":{"rendered":"Business Development and Innovation"},"content":{"rendered":"<section class=\"relative min-h-screen flex items-end \">\n  <div class=\"absolute w-full h-full\">\n    <img loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"1440\" src=\"https:\/\/gebro.es\/app\/uploads\/2023\/12\/hero-business-scaled.jpg\" class=\"w-full h-full object-cover\" alt=\"\" srcset=\"https:\/\/gebro.es\/app\/uploads\/2023\/12\/hero-business-scaled.jpg 2560w, https:\/\/gebro.es\/app\/uploads\/2023\/12\/hero-business-300x169.jpg 300w, https:\/\/gebro.es\/app\/uploads\/2023\/12\/hero-business-1024x576.jpg 1024w, https:\/\/gebro.es\/app\/uploads\/2023\/12\/hero-business-768x432.jpg 768w, https:\/\/gebro.es\/app\/uploads\/2023\/12\/hero-business-1536x864.jpg 1536w, https:\/\/gebro.es\/app\/uploads\/2023\/12\/hero-business-2048x1152.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/>\n  <\/div>\n    <div class=\"absolute w-full h-full bg-gradient-to-t from-blue-900 to-transparent opacity-30\"><\/div>\n    <div class=\"w-full relative z-30 py-20 lg:mt-40\">\n    <div class=\"container flex flex-col gap-y-6 justify-end items-end\">\n      <div class=\"w-full\">\n       <h1 class=\"font-bold text-gray-100 text-5xl leading-none md:text-7xl lg:text-8xl 2xl:text-9xl  lg:w-2\/3 \">Business Development and Innovation <\/h1>\n      <\/div>\n            <hr class=\"border-gray-100 border-t-2 w-full\">\n      <div class=\"text-gray-100 text-lg lg:text-xl 2xl:text-2xl lg:w-2\/5 \">\n        <p>Licensing in &amp; out and partnering strategy<\/p>\n\n      <\/div>\n          <\/div>\n  <\/div>\n<\/section>\n\n\n<section class=\"container py-6  \">\n    <div id=\"breadcrumbs\" class=\"breadcrumbs\"><span><span><a href=\"https:\/\/gebro.es\/en\/\"><i class=\"icon-home\"><\/i><\/a><\/span><\/span><\/div>\n<\/section>\n\n\n<section class=\"container grid grid-cols-12 gap-x-8 gap-y-10 py-6 lg:py-10 overflow-visible relative\">\n  <div class=\"col-span-full lg:col-span-5 flex flex-col gap-6 lg:gap-10 \">\n    <h2 class=\"text-4xl lg:text-5xl 2xl:text-6xl font-bold\">Licensing-in<\/h2>     <p class=\"text-lg lg:text-xl 2xl:text-2xl font-bold\">Laboratorios Gebro Pharma Licensing-In: local player of choice for regional deals<\/p>   <\/div>\n    <div class=\"col-span-full lg:col-span-5 lg:col-end-13 \">\n    <div class=\"text-md lg:text-lg 2xl:text-xl\">\n      <p>The business model of Gebro is based on building up strong brands through active and high-quality promotion to specialists, with a significant investment in scientific activities and value-added marketing. Gebro, proven to be the best marketing partner in its class, focuses on the acquisition, licensing, and development of specialized and innovative healthcare products for human health. Committed to improving the quality of life for individuals, Gebro actively seeks prescription products in the following areas:<\/p>\n\n    <\/div>\n  <\/div>\n    <div class=\"col-span-full lg:col-span-6 relative overflow-scroll hide-scroll max-sm:-mr-4 max-sm:pr-4\">\n    <table class=\"simpletable\">\n      <thead class=\"bg-cyan-500 bg-opacity-20\">\n        <tr>\n          <th><\/th>\n          <th>SPECIALTY<\/th>\n          <th>HOSPITAL<\/th>\n          <th>OTC<\/th>\n        <\/tr>\n      <\/thead>\n      <tbody>\n                <tr>\n          <td class=\"bg-cyan-500 bg-opacity-20\">Austria<\/td>\n          <td>\n            <ul>\n                                          <li>Pain<\/li>\n                            <li>Rheumatology<\/li>\n                            <li>Gastointestinal<\/li>\n                            <li>CNS<\/li>\n                                        <\/ul>\n          <\/td>\n          <td>\n            <ul>\n                                          <li>Anesthetics<\/li>\n                            <li>Oncology<\/li>\n                                        <\/ul>\n          <\/td>\n          <td>\n            <ul>\n                                          <li>Pain<\/li>\n                            <li>Dermatology<\/li>\n                            <li>Cough and cold<\/li>\n                                        <\/ul>\n          <\/td>\n        <\/tr>\n                <tr>\n          <td class=\"bg-cyan-500 bg-opacity-20\">Spain<\/td>\n          <td>\n            <ul>\n                                          <li>Pain<\/li>\n                            <li>Rheumatology<\/li>\n                            <li>Urology<\/li>\n                            <li>Respiratory<\/li>\n                                        <\/ul>\n          <\/td>\n          <td>\n            <ul>\n                                          <li>Pain Units<\/li>\n                            <li>Neurosurgery<\/li>\n                            <li>Haematology<\/li>\n                            <li>Urology<\/li>\n                            <li>Orphan diseases<\/li>\n                                        <\/ul>\n          <\/td>\n          <td>\n            <ul>\n                          <\/ul>\n          <\/td>\n        <\/tr>\n                <tr>\n          <td class=\"bg-cyan-500 bg-opacity-20\">Switzerland<\/td>\n          <td>\n            <ul>\n                                          <li>Pain<\/li>\n                            <li>Rheumatology<\/li>\n                            <li>Dermatology<\/li>\n                            <li>Cough and cold<\/li>\n                            <li>Phytotherapy<\/li>\n                                        <\/ul>\n          <\/td>\n          <td>\n            <ul>\n                                          <li>Orphan diseases<\/li>\n                                        <\/ul>\n          <\/td>\n          <td>\n            <ul>\n                                          <li>Pain <\/li>\n                            <li>Dermatology<\/li>\n                            <li>Cough and cold<\/li>\n                                        <\/ul>\n          <\/td>\n        <\/tr>\n        \n      <\/tbody>\n    <\/table>\n  <\/div>\n    <div class=\"col-span-full lg:col-span-6 \">\n    <img loading=\"lazy\" decoding=\"async\" width=\"690\" height=\"704\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa_business.png\" class=\"w-full\" alt=\"\" srcset=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa_business.png 690w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa_business-294x300.png 294w\" sizes=\"auto, (max-width: 690px) 100vw, 690px\" \/>\n  <\/div>\n  <\/section>\n\n\n<section class=\"container py-6 lg:py-10 \">\n          <div class=\"grid grid-cols-12 gap-x-8 gap-y-10 items-center pb-6\">\n            <div class=\"col-span-full lg:col-span-6 \">\n              <img loading=\"lazy\" decoding=\"async\" width=\"592\" height=\"605\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/business_1.png\" class=\"w-full rounded-xl\" alt=\"\" srcset=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/business_1.png 592w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/business_1-294x300.png 294w\" sizes=\"auto, (max-width: 592px) 100vw, 592px\" \/>\n            <\/div>\n            <div class=\"col-span-full lg:col-span-5 lg:col-end-13 flex flex-col gap-y-6 lg:gap-y-10\">\n              <h3 class=\"text-lg lg:text-xl 2xl:text-2xl font-bold\">Other European\/EEA markets (long-term network partners)\u00a0<\/h3>\n              <div class=\"text-md lg:text-lg 2xl:text-xl rich-text\">\n                Gebro Pharma offers a deep knowledge of the market in its therapeutic interest areas and a great flexibility in both the dealing with partners and the collaboration model. Starting with the Business Development department, all levels within the organization are highly committed to ensure new projects achieve their full potential.\n              <\/div>\n            <\/div>\n          <\/div>\n        <\/section>\n            \n            <section class=\"container py-6 lg:py-10 \">\n          <div class=\"grid grid-cols-12 gap-6 items-center\">\n            <div class=\"col-span-full lg:col-span-5  flex flex-col gap-y-6 lg:gap-y-10\">\n              <h3 class=\"text-lg lg:text-xl 2xl:text-2xl font-bold\">Gebro Group<\/h3>\n              <div class=\"text-md lg:text-lg 2xl:text-xl\">\n                <p>We are a privately-owned family company focused on partnering with a brand-oriented approach. On an international scale, we offer:<\/p>\n<ul>\n<li>Own products available for licensing.<\/li>\n<li>Own structures for products licensed in the established markets of the Gebro Group (Austria, Spain, and Switzerland), as well as for markets within our partner network.<\/li>\n<\/ul>\n\n              <\/div>\n            <\/div>\n                          <div class=\"col-span-full flex flex-col gap-y-2 border-t border-gray-300 py-6\">\n                <p class=\"text-m\">Discover more in:<\/p>\n                <a href=https:\/\/gebro.com\n                  class=\"text-lg font-bold text-cyan-600 underline underline-offset-2 hover:text-cyan-700\">https:\/\/gebro.com<\/a>\n              <\/div>\n                      <\/div>\n                      <div class=\"w-full pb-10 lg:pb-20\">\n              <img loading=\"lazy\" decoding=\"async\" width=\"1216\" height=\"703\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa-business_gran.png\" class=\"w-full\" alt=\"\" srcset=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa-business_gran.png 1216w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa-business_gran-300x173.png 300w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa-business_gran-1024x592.png 1024w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/mapa-business_gran-768x444.png 768w\" sizes=\"auto, (max-width: 1216px) 100vw, 1216px\" \/>\n            <\/div>\n                  <\/section>\n            \n            <section class=\"container py-6 lg:py-10 \">\n          <div class=\"w-full flex flex-col gap-6\">\n                          <p class=\"font-bold text-xl max-w-lg\">Our value proposition is based on these four pillars:\u00a0<\/p>\n                        <div class=\"grid grid-cols-2 lg:grid-cols-4 gap-4 lg:gap-8\">\n                              <div\n                  class=\"relative aspect-3\/5 bg-cyan-500 bg-opacity-20 border border-cyan-500 rounded-lg px-3 py-4 lg:p-4 \">\n                  <p class=\"text-md lg:text-lg 2xl:text-xl\">Partnership oriented and agile in deal making<\/p>\n                  <img decoding=\"async\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/hub.svg\" class=\"absolute bottom-0 right-0 w-32 lg:w-52 h-auto\" alt=\"\" \/>\n                <\/div>\n                              <div\n                  class=\"relative aspect-3\/5 bg-cyan-500 bg-opacity-20 border border-cyan-500 rounded-lg px-3 py-4 lg:p-4 \">\n                  <p class=\"text-md lg:text-lg 2xl:text-xl\">Full commercial sales and marketing capabilities<\/p>\n                  <img decoding=\"async\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/trending_up.svg\" class=\"absolute bottom-0 right-0 w-32 lg:w-52 h-auto\" alt=\"\" \/>\n                <\/div>\n                              <div\n                  class=\"relative aspect-3\/5 bg-cyan-500 bg-opacity-20 border border-cyan-500 rounded-lg px-3 py-4 lg:p-4 \">\n                  <p class=\"text-md lg:text-lg 2xl:text-xl\">Strong know-how in regulatory affairs<\/p>\n                  <img decoding=\"async\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/know-how.svg\" class=\"absolute bottom-0 right-0 w-32 lg:w-52 h-auto\" alt=\"\" \/>\n                <\/div>\n                              <div\n                  class=\"relative aspect-3\/5 bg-cyan-500 bg-opacity-20 border border-cyan-500 rounded-lg px-3 py-4 lg:p-4 \">\n                  <p class=\"text-md lg:text-lg 2xl:text-xl\">Commitment with all our products<\/p>\n                  <img decoding=\"async\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/vacunas.svg\" class=\"absolute bottom-0 right-0 w-32 lg:w-52 h-auto\" alt=\"\" \/>\n                <\/div>\n                          <\/div>\n          <\/div>\n        <\/section>\n            \n            <section class=\"container grid grid-cols-12 gap-x-8 gap-y-6 py-6 lg:py-20 \">\n                      <div class=\"col-span-full\">\n              <h2 class=\"text-4xl lg:text-5xl 2xl:text-6xl font-bold\">Licensing-out<\/h2>\n            <\/div>\n                    <div class=\"col-span-full lg:col-span-5 flex flex-col gap-6 lg:gap-14 \">\n                          <div class=\"flex flex-col gap-6 text-md lg:text-lg 2xl:text-xl\">\n                <p>The Gebro Holding Group markets its own brands and also enters into agreements with third parties for their marketing.<\/p>\n<p>We put healthcare professionals at the center of its momentum. We are passionate about creating our own innovation projects by partnering with recognised public and private research groups and with national institutions of the highest level.<\/p>\n\n              <\/div>\n                                      <div class=\"flex flex-col gap-6 \">\n\n                <div class=\"flex items-center gap-2\">\n                  <input type=\"checkbox\" name=\"healthworkerLeft\" id=\"healthworkerLeft\" class=\"w-4 h-4 healthcare-actioner\">\n                  <label for=\"healthworkerLeft\">\n                    <div class=\"checkbox\"><\/div>\n                    I am a healthcare worker\n                  <\/label>\n                <\/div>\n                <div class=\"hidden\">\n                  <a href=https:\/\/gebro.es\/en\/business-development-and-innovation\/licensing-out\/ class=\"flex flex-row gap-4 items-center text-base lg:text-md 2xl:text-lg font-bold group \"\n                    target=\"\">\n                    <div class=\"transform translate-x-0 group-hover:translate-x-2 transition duration-500 ease-in-out bg-opacity-20 border border-opacity-20 rounded-full w-fit h-auto p-1 lg:p-2  bg-cyan-500 border-cyan-500 text-cyan-500\">\n  <svg class=\"w-6 h-auto\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 24 24\" fill=\"none\">\n<path fill=\"currentColor\" d=\"M16.627 12.75H4.5v-1.5h12.127L10.93 5.554 12 4.5l7.5 7.5-7.5 7.5-1.07-1.054 5.697-5.696Z\"\/>\n<\/svg>\n<\/div>\n                    Read more\n                  <\/a>\n                <\/div>\n\n              <\/div>\n                      <\/div>\n          <div class=\"col-span-full lg:col-span-5 lg:col-end-13 flex flex-col divide-y divide-gray-300\">\n                          <div class=\"text-xl pb-6\">\n                <p>In our <a href=\"https:\/\/www.gebro.com\/en\/\" target=\"_blank\" rel=\"noopener\">headquarters in Austria<\/a>, we offer full development services \u2013 from the idea to the finished product.<\/p>\n<ul>\n<li>A galenical laboratory equipped with state of the art technology.<\/li>\n<li>Development, scale-up and troubleshooting of solid, liquid and semi-solid dosage forms.<\/li>\n<li>Recipe development including production of pre-stability samples.<\/li>\n<li>Scale-up and support of the product transfer to our production facilities through to process validation.<br \/>\nDevelopment and validation of all common analytical methods.;<br \/>\nChemical-physical analysis of test series, pre-stability and ICH stability samples.<\/li>\n<\/ul>\n\n              <\/div>\n                                    <div class=\"col-span-full flex flex-col gap-y-2 border-t border-gray-300 py-6\">\n              <p class=\"text-m\">Discover more in:<\/p>\n              <a href=\"https:\/\/gebro.at\/\"\n                class=\"text-lg font-bold text-cyan-600 underline underline-offset-2 hover:text-cyan-700\">https:\/\/gebro.at\/<\/a>\n            <\/div>\n          <\/div>\n        <\/section>\n            \n                      <section class=\"container grid grid-cols-12 gap-x-8 gap-y-20 py-6 lg:py-20 \">\n            <div class=\"col-span-full lg:col-span-6 flex flex-col gap-6\">\n                              <h2 class=\"text-4xl lg:text-5xl 2xl:text-6xl font-bold\">Innovation model<\/h2>\n                                            <p class=\"text-lg lg:text-xl 2xl:text-2xl font-bold\">First we listen, and then we innovate<\/p>\n                                            <div class=\"flex flex-col gap-6 lg:pr-24 text-md lg:text-lg 2xl:text-xl\">\n                  <p>At Gebro Pharma, <strong>innovation drives us to rethink, reinvent, and optimize medications,<\/strong> placing patients and healthcare professionals at the core of this unstoppable movement. We listen to their needs, and then we innovate.<\/p>\n\n                <\/div>\n                          <\/div>\n                          <div class=\"col-span-full lg:col-span-5 lg:col-start-1\">\n                <p class=\"text-md lg:text-lg 2xl:text-xl font-bold\">\n                  Our innovation model is based on value-added drugs. We employ the VAM (Value Added Medicines) model, grounded in the following principles:\n                <\/p>\n              <\/div>\n              <div class=\"col-span-full lg:col-span-5 lg:col-end-13\">\n                <div class=\"flex flex-col gap-10 prose-p:border-b prose-p:border-cyan-600\">\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Patient Focus\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Rethinking\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Reinventing\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Optimizing medications\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Improving market access\n                    <\/p>\n                                  <\/div>\n              <\/div>\n                          <div class=\"col-span-full lg:col-span-5 lg:col-start-1\">\n                <p class=\"text-md lg:text-lg 2xl:text-xl font-bold\">\n                  The added value we provide in medications is particularly evident in these aspects:\n                <\/p>\n              <\/div>\n              <div class=\"col-span-full lg:col-span-5 lg:col-end-13\">\n                <div class=\"flex flex-col gap-10 prose-p:border-b prose-p:border-cyan-600\">\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Reformulation\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Clinical Program\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Technology\n                    <\/p>\n                                  <\/div>\n              <\/div>\n                      <\/section>\n                    \n                      <section class=\"container py-6 lg:py-20\">\n                          <p class=\"text-md lg:text-lg 2xl:text-xl font-bold max-w-lg\">\n                Our innovation model focuses on the following elements:\n              <\/p>\n                        <img loading=\"lazy\" decoding=\"async\" width=\"2428\" height=\"999\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/innovation.png\" class=\"w-full rounded-xl mt-6\" alt=\"\" srcset=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/innovation.png 2428w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/innovation-300x123.png 300w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/innovation-1024x421.png 1024w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/innovation-768x316.png 768w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/innovation-1536x632.png 1536w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/innovation-2048x843.png 2048w\" sizes=\"auto, (max-width: 2428px) 100vw, 2428px\" \/>\n          <\/section>\n                    \n                      <section class=\"container grid grid-cols-12 gap-x-8 gap-y-20 py-6 lg:py-20 \">\n            <div class=\"col-span-full lg:col-span-6 flex flex-col gap-6\">\n                              <h2 class=\"text-4xl lg:text-5xl 2xl:text-6xl font-bold\">Value Proposition\u00a0<\/h2>\n                                                          <div class=\"flex flex-col gap-6 lg:pr-24 text-md lg:text-lg 2xl:text-xl\">\n                  <p>From our <strong>Innovation Department,<\/strong> we generate ideas for <strong>drugs based on known molecules but providing an additional health benefit<\/strong> to patients and their caregivers. This added benefit to medicines can be in terms of efficacy, safety, dosage, administration route, formulation, or combination, among others. We are passionate about creating our own innovation projects by <strong>collaborating with renowned public and private research groups and institutions<\/strong> at the highest level within the territory. We primarily focus on areas where we excel: autoimmune diseases, pain, respiratory and uroginecology.<\/p>\n\n                <\/div>\n                          <\/div>\n                          <div class=\"col-span-full lg:col-span-5 lg:col-start-1\">\n                <p class=\"text-md lg:text-lg 2xl:text-xl font-bold\">\n                  Our strength in making agreements is based on these points:\n                <\/p>\n              <\/div>\n              <div class=\"col-span-full lg:col-span-5 lg:col-end-13\">\n                <div class=\"flex flex-col gap-10 prose-p:border-b prose-p:border-cyan-600\">\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Agility in decision-making and agreement negotiations\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Know-how in Regulatory Affairs\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Strong relationships with authorities for price and reimbursement negotiations\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Availability of internal resources for promotion and investment in new products\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Long-term commitment to all our products\n                    <\/p>\n                                      <p class=\"pb-6 text-xl font-bold\">\n                      Development of commercial activities with added value\n                    <\/p>\n                                  <\/div>\n              <\/div>\n                      <\/section>\n                    \n            <section class=\"container py-6\">\n          <div class=\"text-md lg:text-lg 2xl:text-xl max-w-sm\">\n            <p>We have a virtual <strong>Research and Development<\/strong> model in which the organization works with a limited number of internal staff and utilizes external resources, technologies, and facilities on demand to develop its R&amp;D projects. This model <strong>offers numerous advantages,<\/strong> such as <strong>reduced capital requirements, overall costs, and financial risks, limited infrastructure costs<\/strong>, and, of course, <strong>greater flexibility.<\/strong><\/p>\n\n          <\/div>\n        <\/section>\n            \n                      <section class=\"container py-6 lg:py-20\">\n                          <p class=\"text-md lg:text-lg 2xl:text-xl font-bold max-w-lg\">\n                Market pull:\n              <\/p>\n                        <img loading=\"lazy\" decoding=\"async\" width=\"2428\" height=\"521\" src=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/market-pull-1.png\" class=\"w-full rounded-xl mt-6\" alt=\"\" srcset=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/market-pull-1.png 2428w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/market-pull-1-300x64.png 300w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/market-pull-1-1024x220.png 1024w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/market-pull-1-768x165.png 768w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/market-pull-1-1536x330.png 1536w, https:\/\/gebro.es\/app\/uploads\/2024\/02\/market-pull-1-2048x439.png 2048w\" sizes=\"auto, (max-width: 2428px) 100vw, 2428px\" \/>\n          <\/section>\n                \n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-business.blade.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-128","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Business Development and Innovation - Gebro Pharma<\/title>\n<meta name=\"description\" content=\"We actively pursue synergies to boost innovation through partnerships and licensing-in and licensing-out agreements.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gebro.es\/en\/business-development-and-innovation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Business Development and Innovation - Gebro Pharma\" \/>\n<meta property=\"og:description\" content=\"We actively pursue synergies to boost innovation through partnerships and licensing-in and licensing-out agreements.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gebro.es\/en\/business-development-and-innovation\/\" \/>\n<meta property=\"og:site_name\" content=\"Gebro Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-25T13:42:57+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/business-development-and-innovation\\\/\",\"url\":\"https:\\\/\\\/gebro.es\\\/en\\\/business-development-and-innovation\\\/\",\"name\":\"Business Development and Innovation - Gebro Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/#website\"},\"datePublished\":\"2023-12-13T09:45:33+00:00\",\"dateModified\":\"2026-02-25T13:42:57+00:00\",\"description\":\"We actively pursue synergies to boost innovation through partnerships and licensing-in and licensing-out agreements.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/business-development-and-innovation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/gebro.es\\\/en\\\/business-development-and-innovation\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/business-development-and-innovation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\",\"item\":\"https:\\\/\\\/gebro.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Business Development and Innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/gebro.es\\\/en\\\/\",\"name\":\"Gebro Pharma\",\"description\":\"At Gebro Pharma we improve your health\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/gebro.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Business Development and Innovation - Gebro Pharma","description":"We actively pursue synergies to boost innovation through partnerships and licensing-in and licensing-out agreements.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gebro.es\/en\/business-development-and-innovation\/","og_locale":"en_US","og_type":"article","og_title":"Business Development and Innovation - Gebro Pharma","og_description":"We actively pursue synergies to boost innovation through partnerships and licensing-in and licensing-out agreements.","og_url":"https:\/\/gebro.es\/en\/business-development-and-innovation\/","og_site_name":"Gebro Pharma","article_modified_time":"2026-02-25T13:42:57+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/gebro.es\/en\/business-development-and-innovation\/","url":"https:\/\/gebro.es\/en\/business-development-and-innovation\/","name":"Business Development and Innovation - Gebro Pharma","isPartOf":{"@id":"https:\/\/gebro.es\/en\/#website"},"datePublished":"2023-12-13T09:45:33+00:00","dateModified":"2026-02-25T13:42:57+00:00","description":"We actively pursue synergies to boost innovation through partnerships and licensing-in and licensing-out agreements.","breadcrumb":{"@id":"https:\/\/gebro.es\/en\/business-development-and-innovation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gebro.es\/en\/business-development-and-innovation\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/gebro.es\/en\/business-development-and-innovation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"","item":"https:\/\/gebro.es\/en\/"},{"@type":"ListItem","position":2,"name":"Business Development and Innovation"}]},{"@type":"WebSite","@id":"https:\/\/gebro.es\/en\/#website","url":"https:\/\/gebro.es\/en\/","name":"Gebro Pharma","description":"At Gebro Pharma we improve your health","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gebro.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/pages\/128","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/comments?post=128"}],"version-history":[{"count":5,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/pages\/128\/revisions"}],"predecessor-version":[{"id":1933,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/pages\/128\/revisions\/1933"}],"wp:attachment":[{"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/media?parent=128"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}